Professor David Price
Chair of Primary Care Respiratory Med
- About
-
- Email Address
- d.price@abdn.ac.uk
- Telephone Number
- +44 (0)1224 437237
- School/Department
- School of Medicine, Medical Sciences and Nutrition
- Publications
-
Page 20 of 93 Results 191 to 200 of 924
Real-life biomarker response to anti-IL5 and anti-IgE therapies in severe asthma patients
European Respiratory Society (ERS) International Congress., 3305Contributions to Journals: AbstractsRisk factors for corticosteroid- and antibiotic only-treated asthma attacks in the NOVELTY cohort
European Respiratory Society (ERS) International Congress., 2125Contributions to Journals: AbstractsWhat have we learnt from real-life research in asthma and COPD?: Standards and novel designs for the future
Respirology, vol. 27, no. 12, pp. 1018-1021Contributions to Journals: Comments and Debates- [ONLINE] DOI: https://doi.org/10.1111/resp.14381
Effectiveness of initiating biologics in severe asthma patients with high steroid exposure
European Respiratory Society (ERS) International Congress., 3405Contributions to Journals: AbstractsProactive Risk Management: A Novel Approach to Embedding Oral Corticosteroid Stewardship into Asthma Care
European Medical Journal - Respiratory, vol. 10, no. Supplement 2Contributions to Journals: ArticlesAdverse outcomes following initiation of oral corticosteroids for chronic obstructive pulmonary disease: long-term observational study
British Thoracic Society Winter Meeting 2022, pp. A54Contributions to Conferences: AbstractsS88 Adverse outcomes following initiation of oral corticosteroids for chronic obstructive pulmonary disease: long-term observational study
Thorax, vol. 77, no. Suppl. 1, pp. A54Contributions to Journals: AbstractsP186 Facilitators to recruiting COPD patients to an adherence intervention trial
Thorax, vol. 77, no. Suppl. 1, A182Contributions to Journals: Abstracts- [ONLINE] DOI: https://doi.org/10.1136/thorax-2022-BTSabstracts.320
Poor adherence in exacerbating COPD patients: magnitude and related factors at baseline in the MAGNIFY pragmatic trial
British Thoracic Society Winter Meeting 2022, pp. A72-A73Contributions to Journals: AbstractsDupilumab Treatment Leads to Sustained Reductions in Oral Corticosteroid Use in Patients With Oral Corticosteroid-Dependent Severe Asthma
CHEST 2022, pp. A1909-A1913Contributions to Journals: Abstracts